Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Resmetirom intermediate offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Novel double-protection strategy enhances purity and yield for idarubicin hydrochloride. Streamlined process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel amide-type solanesol derivatives with antitumor activity. Efficient synthesis via mild coupling ensures high purity and cost-effective manufacturing for pharma applications.
Patent CN114276286A reveals a novel one-pot synthesis of N,N-disubstituted-alpha,beta-unsaturated enamines using DMSO and base, offering significant cost reduction in API manufacturing.
Novel 5-(2-(disubstituted phosphino)phenyl)-1-alkyl-1H-pyrazole ligands enable low-loading Pd catalysis for Kumada and Negishi reactions with high yields.
Novel chlorination-coupling method for alpha nucleosides. Reduces purification steps, improves selectivity for antisense drug manufacturing.
Patent CN118852253B reveals metal-free visible light catalysis for high-purity heterocyclic compounds offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN109912531B details a novel purification method for Febuxostat intermediates, achieving 99.8% purity and significantly improved yields for cost-effective manufacturing.
Patent CN107245070B details a novel purification method reducing genotoxic impurities in Imatinib to below 2ppm with over 99.8% purity, offering significant cost and supply chain advantages.
Patent CN107033079A details a high-purity Eslicarbazepine Acetate method. Achieve cost reduction and supply chain reliability with scalable pharmaceutical manufacturing.
Patent CN121159409A reveals a one-step hydrolysis method for 5-nitro-2-aminophenol. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111454222A details a metal-free, one-step synthesis of quinazoline diones using CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced preparation method for penehyclidine impurities via epoxide ring-opening. Offers high purity, simplified processing, and reliable supply for pharmaceutical quality control.
Patent CN116693374A details high-yield 1,3-diacylbenzene synthesis. Offers cost-effective scalable solutions for global pharmaceutical intermediates supply chains.
Patent CN105646634A details novel impurity synthesis routes ensuring high purity pharmaceutical intermediates supply chain stability and cost efficiency for global buyers.
Patent CN1781915A reveals a high-yield, safe process for oxazolylethanol derivatives, replacing hazardous reagents with aqueous systems for cost-effective API manufacturing.
Patent CN115490613B details a novel decarbonylative cyanation method using zinc cyanide, offering significant cost and supply chain advantages for high-purity aromatic nitrile manufacturing.
Patent CN107417543B introduces a safe, solid-reagent method for brominating fused-ring aromatics, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1043646C details a high-yield d4T process avoiding hazardous reagents, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced one-step process for high-purity dexamethasone sodium phosphate. Reduces production costs and enhances supply chain reliability for API manufacturing.